Reiss Joel reported grant involving 19,250 derivative units of TransDigm Group INC at $0.00 for $0 on Nov 3, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Co-Chief Operating Officer
Co-Chief Operating Officer
Filed Nov 5, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
19,250Stock Option
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
19,250Direct
Trade date
Nov 3, 2026Grant
Filed
Nov 5, 2026, 5:12 PM ET2-day reporting delay
Accession
0001656109-26-000010Code A · Transaction 393754
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

TDG price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
TDG · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −8.3%1w ago −5%1d ago +2.1%
Returns since7d +1.2%30d90d180d1y

Footnotes in full

F1: 7,600 options are exercisable at 20% per year over five years beginning September 30, 2027, subject to achievement of annual operating performance targets each year. 11,650 options are exercisable in two equal installments on September 30, 2030, and September 30, 2031, subject to achievement of annual operating performance targets each year.